background: Although the age-effect on in vitro fertilization outcomes has been well documented, data on donor insemination are scarce hampering accurate patient counseling. This cohort study therefore aims at analyzing cumulative delivery rates after donor insemination for various indications.
Introduction
Postponing childbearing is a social trend and has led to an increase in treatments for age-related female subfertility (Broekmans et al., 2007) . However, there is an age-related decrease in success rates of these treatments (van Noord-Zaadstra et al., 1991; Hull et al., 1996) . Patients undergoing fertility treatments need to be clearly informed about their chances of having a baby. Therefore, it is important for both candidate couples and fertility specialists treating them to know the probability for delivery after a defined number of treatment cycles. The cumulative chances of achieving a live birth after a given number of cycles are obviously more meaningful than the live birth rate per cycle.
Although this information is currently available for assisted reproduction by in vitro fertilization and intra-cytoplasmic sperm injection (Osmanagaoglu et al., 1999 (Osmanagaoglu et al., , 2002 Elizur et al., 2006) , only limited data are available for intrauterine insemination with donor insemination (CECOS, 1982; Barret and Cooke, 1993; Botchan et al., 2001; Custers et al., 2008; Dovey et al., 2008) .
There have been many reports about the success rates per cycle, but cumulative delivery rates in different age groups for artificial insemination with donor sperm (AID) have never been studied on large patient populations. Especially for older patients, these data are very important. Therefore, the aim of this study was to analyze the cumulative delivery rates on patients undergoing donor insemination according to their age and to analyze whether ovarian stimulation treatment and indication for AID had any effect on the success rates.
Materials and Methods

Insemination
In this retrospective study, we examined the outcome of insemination using cryopreserved donor semen in 1654 women who started their first treatment cycle between January 2000 and December 2005. They underwent a total of 6630 donor insemination cycles. None of these patients had had a previous delivery and ,10% had been pregnant in the past. The indications for donor insemination were severe male infertility, requests from lesbian couples and single-parent requests. All women were assumed to be normally fertile, since they had a normal fertility work-up including either hysterosonography or hysterosalpingography or laparoscopy. Although patients had normal menstrual cycles, some patients did receive mild ovarian hyperstimulation (MOH) either with clomiphene citrate 50 -100 mg from Day 3 till Day 7 of the menstrual cycle or human menopausal gonadotrophins 75-150 U from Day 3 of their cycle onwards. Although there is no evidence that adding MOH to otherwise normally cycling patients will increase the success rates in intrauterine insemination (IUI) using frozen-thawed donor sperm, patients receiving MOH did so because their referring physician opted to apply MOH. All patients received one single IUI performed 36-44 h after injecting 5000 U hCG (Pregnyl, Organon, Oss, The Netherlands) whenever ultrasound showed the presence of one to a maximum three follicles measuring at least 17 mm in diameter. IUI was performed using frozen-thawed donor sperm with a minimum of 1 Â 10 6 progressively motile spermatozoa being inseminated using a Frydman catheter (Laboratoires CCD, Paris, France). Sperm for insemination was prepared by a two-layer density gradient (Pure sperm TM , Nidacon, Mö lndal, Sweden) after thawing. From the evening of the day of insemination, patients were advised to use intravaginal micronized progesterone 3 Â 200 mg (Utrogestan, Besins, Paris France). Our patients received blocks of four cycles of donor insemination before returning to their doctor.
Pregnancies were diagnosed by a standard serum assays for hCG showing levels of .10 IU/l on at least two consecutive occasions. Clinical pregnancies were evidenced by the presence of an intrauterine gestational sac at ultrasound. Pregnancy follow-up was done by sending questionnaires to patients and their doctor or by telephone queries whenever questionnaires were incomplete. Live birth delivery after 25 weeks of gestation was the main outcome measure of our study.
Patients who did not return their questionnaire or who discontinued their treatment without further notice were contacted by phone in order to obtain the following information: their status with regard to treatment (no further treatment or still continuing treatment), occurrence with or without infertility treatment of a pregnancy outside our department and reasons for discontinuing treatment.
Data analysis
For each group of interest, categorical variables are presented as number of cases including nominator and denominator values and percentages. Comparisons of percentages among groups were performed by using the Fisher's exact probability for each comparison made.
The primary outcome of this retrospective cohort study was delivery resulting in at least one live birth. The delivery of more than one child was given the same weight as the delivery of a singleton. Patients were not re-enrolled after having a first delivery. Each miscarriage was included in the count of the cycles, until the patients reached the final outcome.
In line with previous reports from our institution, we provide two approaches frequently employed to estimate the effectiveness of assisted reproduction technology (ART) treatment according to the number of cycles. The first method calculates outcome by dividing the number of women achieving live birth delivery up to a predetermined number of cycles (numerator) by the total number of women who started treatment with AID (denominator). The outcome measure associated with this method is referred to as 'Crude cumulative delivery rate'. The other method estimates the cumulative live birth delivery rate after a specified number of cycles using life-table analysis, by taking into account the effects of censoring (drop-out). The outcome measure associated with this method is referred to as 'Expected cumulative delivery rate'. As these outcome measures cannot be transformed to a similar unit, the outcomes of both methods cannot be readily compared. Basically, the first method does not take into account drop-out (censoring) and provides a conservative estimate of outcome.
Expected cumulative delivery rates (curves) were compared by log-rank tests. Cox's proportional hazard model was used to perform a multivariate analysis. A P-value of 0.05 or less is considered as statistically significant. Apart from comparisons according to indication and controlled ovarian stimulation protocol, cumulative delivery rates were compared for five subgroups according to patient 's age, i.e. 20-29, 30-34, 35-37, 37-39 and 40-45 years old, at the first insemination of the treatment course. Age at first insemination treatment determined the group to which our patients belonged, i.e. if a patient was 29 years old at her first insemination cycle, she was allocated to the 20-29 age group. The last age group was further subdivided for further analysis into four subgroups: 40, 41, 42 and 43 years or older. For the controlled ovarian stimulation protocol, only the last cycle of the woman was taken into account, i.e. time-dependent covariates in Cox regression or other methods to examine the effect of stimulation treatments which change from cycle to cycle were not used in the current analyses.
Computational procedures were performed using Statistics Package for Social Sciences for Windows version 16 (SPSS Inc., Chicago, IL, USA).
Results
Baseline characteristics
Tables I and II provide information about the background of the 1654 patients treated, including the numbers with the different reasons for donor insemination, the different stimulation protocols and the different age groups. Overall, in our series, the most frequent indication for AID came from lesbian couples, clomiphene citrate was most frequently used for controlled ovarian stimulation, and most patients belonged to the 30 -34 age group.
Several statistically significant and clinically relevant between-group differences were observed. With advancing age, there was a gradual increase in the proportion of single-parent requests and a decline in the proportion of lesbian women undergoing donor insemination (Table I) . Clomiphene citrate was more frequently used in lesbian women (Table II) .
Overall success rates
There were 1654 women who underwent a total of 6630 treatment cycles. The number of cycles ranged from 1 to 24. We were unable to collect information on outcome in only ,3% of the women. Overall, 928 deliveries were recorded (14% per cycle). In the first cycle, the average delivery rate was 19% and thereafter rates varied between 9% and 14% per cycle. The crude and expected cumulative delivery rates for the whole group were 56% and 77%, respectively (Table III, upper panel) . After the fifth cycle, the accrual in delivery rates became less pronounced and reached a plateau at the eighth cycle in all age groups below 40. There was no change in the pregnancy rate over the course of the study (data not shown).
A total of 1020 babies were born, of which 89 were twins. Of the 89 twins, 75 patients took clomiphene citrate, 11 women used gonadotrophins and only 3 used no medication. In the oldest group, none of the women had twins. Intrauterine death occurred in two pregnancies. Three women delivered triplets.
Among 912 pregnancies during the first six cycles, there were 103 miscarriages (11.9%). Miscarriage rates after six cycles were 6.4% for the 20-29 years age group, 8.0% for the 30-34 years age group, 10.4% for the 35 -37 years age group, 20.8% for the 38-39 years age group and 31.9% for the 40-45 years age group. In the oldest group, there were 23 miscarriages in 72 pregnancies. There were 11 ectopic pregnancies (1.3%) in the 912 pregnancies after six cycles.
We noted no complications related to treatment or artificial insemination. The prematurity rate (,37 weeks) was 5.1%. The mean infant weight at birth for single pregnancies was 3310 g (standard deviation 478 g) and the incidence of children born weighing ,2500 g was 4.8%.
Age and success rates Figure 1 shows the expected cumulative delivery rates for the total patient group stratified according to age, whereas Table III provides more detailed data (including 95% confidence intervals). The lower panels of Table III show the crude and expected cumulative delivery rates stratified according to age together with the drop-out rates and delivery rates per cycle up to 12 cycles after starting treatment. As expected, delivery rates decreased significantly with increasing female age (log-rank test P , 0.001).
Subgroup analysis in the oldest group (40 -45 years; n ¼ 223 patients) revealed a crude and expected cumulative delivery rates of 26% and 52% after 12 cycles, respectively, despite the drop-outs occurring mainly as a result of discouraging patients to continue their treatment for the reason of their advanced age (Table IV) . Only one patient discontinued treatment because of medical reasons.
In the group starting treatment at age 40, the crude and expected cumulative delivery rates were 35% and 55%, respectively, after nine cycles, after which a plateau was reached. In the group starting treatment at age 41, the cumulative delivery rates reached a plateau after six cycles.
In the group starting treatment at age 42, both the crude and the expected cumulative delivery rates reached a plateau at 9% from cycle 2 till cycle 11. One additional delivery in one patient occurred after cycle 12, increasing the expected cumulative delivery rate from 9% to 32%.
In the group starting treatment at age 43 or later, a plateau was reached after three cycles, but one delivery occurred after the sixth cycle. As indicated in Table IV , only a small number of women aged 43 years or over were available. Figure 2 shows the expected cumulative delivery rates among patients aged 40 years or older when starting treatment.
Effects of age, indication and stimulation protocol on success rate
Overall, our Cox regression analysis on the total group, with live birth delivery as the outcome (dependent) variable and age group indication, and controlled ovarian stimulation protocol as explanatory (independent) variables, indicated that age was the only factor that had a significant and independent effect on success (Tables V and  VI) . Overall, older women are less likely to achieve a successful delivery. Adjustment for the indication for donor insemination had no effect on the cumulative delivery rates. Likewise, there was no effect Continued of adjustment for controlled ovarian stimulation on the cumulative delivery rates. For the subgroup of patients aged 43 or over, our Cox regression analysis should be interpreted with some caution given the small number of women starting treatment and the small number of deliveries, especially among women over the age of 43 (Table VI) .
Discussion
Although our study confirms the impact of age on donor insemination outcome in terms of live birth delivery, we observed acceptable cumulative delivery rates after donor insemination, even in older age subgroups.
Many women in industrialized societies want to delay reproduction because they give priority to their careers or simply did not meet the right partner. This trend is also present in women seeking treatment with donor insemination. Knowing the probability of delivering a baby after fertility treatment is important for both the candidate mother and her fertility specialist.
The effect of age on the success rate of infertility treatments has been well documented. Increasing age is associated with a decrease in pregnancy rate and the eventual delivery rate. This applies to either natural conception (Dunson et al., 2004) or ART (Federation CECOS, 1982; Van Noord-Zaadstra et al., 1991; Scott et al., 1995 Figure 1 Cumulative live birth delivery rates after donor insemination in five pre-specified age groups, i.e. 20 -29, 30 -34, 35-37, 38 -39, 40 -45 Continued in the numbers of oocytes obtained (Faddy and Gosden, 1996) , to an increase in the incidence of aneuploidy in oocytes (Munné et al., 1995) and to poor oocyte quality (Navot et al., 1991) . Age is therefore the most important limiting factor for the success of reproductive treatments.
Unfortunately, in the literature, few reports deal with the effect of age on the outcome of donor insemination. Botchan et al. (2001) described the results of 6139 artificial insemination cycles with donor spermatozoa. The author investigated only the cumulative pregnancy rates but not the cumulative delivery rates. They described Figure 2 Cumulative live birth delivery rates after donor insemination in four pre-specified age subgroups of the oldest patients, i.e. 40, 41, 42 and the .43 years age groups.
Cumulative delivery rates in donor insemination cumulative pregnancy rates after 3, 6 and 12 months but not after each cycle as in this study. The CECOS 1982 study reported on 2193 women who were receiving AID and whose husbands were totally sterile. Outcome in four age groups was reported as pregnancy and not as delivery after 25 weeks, as in our study. The CECOS 1982 study included only 144 patients in the oldest group and only 14 patients older than 40 years. They reported a cumulative success rate of 53.6% after 12 cycles in the group of patients aged 35 years and more. We included 784 patients aged 35 years or more, reaching an expected cumulative delivery rate of up to 76%. As a general rule, providing an accurate answer about the success rates for elderly women remains hampered by a lack of power related to the small number of women included and the low number of delivery events observed. Barrett and Cook reported a cumulative pregnancy rate of 54% after 12 cycles of AID treatment above the age of 36. Unfortunately, their report provides no details about the number of patients treated in specific age groups.
In line with a report published by Lansac and Royère (2001) , we observed a prematurity rate (,37 weeks) of 5.1%. Our data on mean infant weight also confirm the results published by Schoysman et al. (1981) and Hoy et al. (1999) showing that, compared with the general population, AID is not associated with a significant difference in the prevalence of preterm birth, low birthweight or perinatal mortality.
In the current study, we aimed at analyzing delivery rates after donor insemination according to different age groups using life-table analyses. Methodological strengths of our study include the large sample size, the consecutive recruitment of unselected patients, a virtually complete patient follow-up, the choice of live birth delivery as the outcome event of primary interest and the use of well-validated methods to present both crude and expected cumulative delivery rates and to model cumulative delivery using a standard (Cox regression) technique.
This cohort study, being retrospective in nature, has some weaknesses as well. In order to minimize age-bias, we analyzed a large consecutive series which was divided into six age groups. The drop-out rate in the older groups was much higher than in the younger groups, however, not because of medical reasons or absence of follicular development. The most important reason was the advice of the treating doctor to refrain from any further treatment because of his anticipation of low success rates associated with advancing age. Only in the 42-year-old age group was there one patient who did not have adequate follicular development.
Life-table analysis has been used to estimate the success rates of various techniques of reproductive surgery and assisted reproduction (Hull et al., 1992) . Life-table analysis assumes that those patients who continue their treatment and those who quit their treatment for nonmedical reasons have the same probability of achieving the defined event (e.g. delivery) (Stolwijk et al., 1996) . Some authors argue that patients who discontinue the treatment may have done so because of poor treatment prognosis (Doody, 1993; Walters, 1994) . However, another study (Haan et al., 1991) found no overrepresentation of patients with a poor prognosis in the group of dropouts. It has been suggested (Engmann et al., 1999) of the cumulative delivery rate will consider her to be 32 years. This calculation method thus introduces a biased decline due to advancing female age (Engmann et al., 1999) . Life-table analysis also tends to overestimate the estimated cumulative delivery rates when the group is too small. Although we included a large total number of patients, fewer patients of advanced age asked for AID, and hence the older age groups included limited numbers of patients. This is quite well illustrated by our data: after the ninth cycle in the 40 -45 years group, for example, the expected cumulative delivery rate of 40% increases up to 52% due to three additional deliveries in a subgroup of 16 women. In the current series, all cumulative delivery rates are presented with corresponding 95% confidence intervals. In doing so, we provide information to the reader on magnitude and precision of cumulative delivery rates at each cycle, as well as the role that chance may play in the observed study results. Finally, we can conclude that age was the only factor that had a significant and independent effect on success of the donor insemination. Neither indication nor ovarian stimulation had any effect on the delivery rates. However, since we did not use time-dependent covariates in Cox regression or other methods to examine the effect of stimulation treatments which change from cycle to cycle, the last stimulation in a patient being used to represent the overall effect of stimulation may not be sensitive to detect the effects of stimulation on pregnancy rates.
Overall, and despite some methodological limitations, the data of this cohort study show that up to 42 years, the cumulative delivery rates after donor insemination are acceptable. Patients can be counseled according to these data regarding their chances of obtaining a delivery. Although based on retrospective data, we could not establish a role for controlled ovarian stimulation in order to improve the success rate in these otherwise normally cycling women, not even in the advanced age groups.
